title: [Diagnosis and treatment of Pompe disease].
abstract: Pompe disease is a rare, progressive and often fatal neuromuscular disorder. It is caused by a deficiency of the lysosomal alpha-glucosidase. Among glycogen storage disorders, it is one of the most common. Its clinical manifestations can start at any moment of life, with a very variable symptomatology. In this article, we show an extended revision of the literature in regards to the main medical aspects of Pompe disease: etiology, psychopathology, epidemiology, clinical variants, pathological diagnosis, and enzyme replacement therapy. With this information, we created a diagnostic and therapeutic guide, which is addressed to specialists and to first-level physicians, in order to let them identify both the classic and the late forms of this disease. We describe as well the best, timely, multidisciplinary treatment in use. Also, we show some suggestions to the proper functioning of health institutions, and routes to diagnosis. We conclude that Pompe disease may be properly diagnosed and treated if health care professionals follow the internationally approved recommendations.
authors.affiliation: Departamento de Neuropediatría, Hospital Central "Dr. Ignacio Morones Prieto," San Luis Potosí, San Luis Potosí, Mexico. antoniobravooro@hotmail.com.
authors.forename: Antonio
authors.initials: A
authors.lastname: Bravo-Oro
authors.forename: Beatriz
authors.initials: B
authors.lastname: de la Fuente-Cortez
authors.forename: Avril
authors.initials: A
authors.lastname: Molina-García
authors.forename: Víktor
authors.initials: V
authors.lastname: Romero-Díaz
authors.forename: Ildefonso
authors.initials: I
authors.lastname: Rodríguez-Leyva
authors.forename: María del Carmen
authors.initials: Mdel C
authors.lastname: Esmer-Sánchez
mesh_terms: D000465:Algorithms; D006009:Glycogen Storage Disease Type II / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans
keywords: enfermedad de almacenamiento de glucógeno tipo II; enzyme replacement therapy; glycogen storage disease type II; terapia de reemplazo enzimático